O'GORMAN CEDRIC (Chief Medical Officer) purchased 8264.5% of their position (10K shares) of RELMADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $31.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/24/2023ACC: 0001213900-23-042554
Officer· Chief Medical Officer
Since Jan 2023
+10K
Net shares
Net buyer
$31.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$3.18
Trade value
$31.80K
% of position
8264.5%
5/23/2023
121.00→10.12K
Total
Net shares
+10K
Net value
$31.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/23/2023 | P · Purchase | +10K | $3.18 | $31.80K | 8264.5% | 121.00 | 10.12K |
| Total | +10K | $31.80K | ||||||
Derivative Transactions0
No derivative transactions reported